The current disclosure relates to methods for treating ovarian cancer based on specific antigen expression of the cancer. Furthermore, the expressed antigen may be used in immunotherapeutic methods for treatment of the ovarian cancer. Aspects of the disclosure relate to immunotherapies targeting CT45 polypeptides, methods for treating ovarian cancer based on CT45 expression, and kits for detecting CT45 polypeptides and nucleotides.
Details
Title
METHODS OF TREATING CANCERS WITH CT45 TARGETED THERAPIES
Inventors
Lengyel, Ernst : University of Chicago Mann, Matthias : Max Planck Institute of Biochemistry Curtis, Marion : University of Chicago Coscia, Fabian : Max Delbrück Center for Molecular Medicine
Applicants
University of Chicago Max Planck Gessellschaft
Content Type
Patent
Assignees
University of Chicago Max Planck Gesellschaft zur Foerderung der Wissenschaften eV
